Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.

scientific article published on 23 November 2015

Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3233/JAD-140669
P698PubMed publication ID26599049

P50authorSimon LovestoneQ30582986
Iwona KłoszewskaQ38633661
Hilkka SoininenQ38636823
Patrizia MecocciQ46713839
Mizanur KhondokerQ47163880
Petroula ProitsiQ47504060
Magda N. TsolakiQ57073392
Bruno VellasQ66877204
Martina SattleckerQ114432270
P2093author name stringStephen Williams
Richard Jb Dobson
P2860cites workSystematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesQ27860739
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsQ28131785
Inflammation and Alzheimer's diseaseQ28138617
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosisQ28217930
Aptamer-based multiplexed proteomic technology for biomarker discoveryQ28744329
Plasma based markers of [11C] PiB-PET brain amyloid burdenQ34427001
Proteome-based plasma biomarkers for Alzheimer's diseaseQ34577503
A serum protein-based algorithm for the detection of Alzheimer diseaseQ34755504
Inflammatory proteins in plasma are associated with severity of Alzheimer's diseaseQ34769550
Decreased serum albumin levels in Taiwanese patients with schizophreniaQ35027007
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer diseaseQ35034130
A blood-based algorithm for the detection of Alzheimer's diseaseQ35203409
Lower residual renal function is a risk factor for depression and impaired health-related quality of life in Korean peritoneal dialysis patientsQ35639050
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer diseaseQ36183810
Chemokines and brain functionsQ36230513
Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptideQ36401494
Role of complement in neurodegeneration and neuroinflammation.Q36477580
Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activityQ36752538
Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteinsQ36927870
Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer diseaseQ36932748
Biological marker candidates of Alzheimer's disease in blood, plasma, and serum.Q37617521
Plasma biomarkers for Alzheimer's disease: much needed but tough to findQ38037157
Parkinson's disease plasma biomarkers: an automated literature analysis followed by experimental validation.Q38079416
Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chainsQ39654001
The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysisQ42126660
Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons.Q44597455
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteinsQ44917427
Decreased plasma antioxidants in schizophreniaQ44922740
Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer's diseaseQ45892444
Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's diseaseQ46155330
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseQ47378944
Reduced plasma antioxidants in first-episode patients with schizophreniaQ47789195
Serum amyloid P component induces neuronal apoptosis and β-amyloid immunoreactivityQ48183927
Biomarkers in brain disease. PrefaceQ48411055
C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's diseaseQ48796828
Total serum protein and serum protein fractions in depression: relationships to depressive symptoms and glucocorticoid activityQ48822082
Serum IL-6, albumin and co-morbidities are closely correlated with symptoms of depression in patients on maintenance haemodialysisQ49128065
Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology.Q50646784
Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio.Q51736251
Immunodetection of the amyloid P component in Alzheimer's disease.Q53187403
Abnormal serum concentrations of proteins in Parkinson's disease.Q53497967
P433issue4
P921main subjectblood plasmaQ79749
P304page(s)1105-1114
P577publication date2015-11-23
P1433published inJournal of Alzheimer's DiseaseQ6294755
P1476titleLongitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.
P478volume49

Reverse relations

cites work (P2860)
Q51760901A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.
Q93080662Alterations in Alzheimer's Disease-Associated Gene Expression in Severe Obstructive Sleep Apnea Patients
Q54982684Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.
Q63977287Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients
Q60950950Blood-Derived Plasma Protein Biomarkers for Alzheimer's Disease in Han Chinese
Q64108130Blood-based molecular biomarkers for Alzheimer's disease
Q93080975Fine-Mapping of the Human Blood Plasma N-Glycome onto Its Proteome
Q92436802Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
Q60045873Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease

Search more.